Thyroid dysfunction and long-term outcome during and after interferon-alpha therapy in patients with chronic hepatitis C

Themistoklis VASILIADIS; Vasiliadis THEMISTOKLIS; Panagiotis ANAGNOSTIS; Anagnostis PANAGIOTIS; Georgios NALMPANTIDIS; Nalmpantidis GEORGIOS; Konstantinos SOUFLERIS; Soufleris KONSTANTINOS; Kaliopi PATSIAOURA; Patsiaoura KALIOPI; Nikolaos GRAMMATIKOS; Grammatikos NIKOLAOS; Eleni ORFANOU-KOUMERKERIDOU; Orfanou-Koumerkeridou ELENI; Konstantinos KARGIOTIS; Kargiotis KONSTANTINOS; Aristidis SLAVAKIS; Slavakis ARISTIDIS; Aristidis DELIYIANNIDIS; Deliyiannidis ARISTIDIS; Nikolaos EUGENIDIS; Eugenidis NIKOLAOS.
Annals of the Academy of Medicine, Singapore ; : 394-400, 2011.
Artículo en Inglés | WPRIM | ID: wpr-229643

Documentos relacionados

  1. Indicaciones y Complicaciones del Implante de Marcapasos Endocárdico Percutáneo Definitivo en Paciente del Hospital Militar Central de El Salvador en el Periodo de Enero 2018 a Diciembre 2021
  2. [Precise immunological classification guidance for early initiation of antiviral therapy in patients with chronic HBV infection].
  3. Pharmacological interventions for acute hepatitis C infection.
  4. The Severity of Depressive Symptoms as an Independent Predictor of Sustained Virological Response During Treatment of Hepatitis C With Pegylated Interferon-α2a and Oral Ribavirin.
  5. Approach to a patient with hepatitis c: diagnosis and pretreatment assessment.
  6. Editorial: Benefit of Direct-Acting Antiviral Therapy For Cryoglobulinemia due to Hepatitis C Infection.
  7. Epidemiology, risk factors and prognosis of Interferon alpha induced thyroid disorders. A Prospective Clinical Study.
  8. You Can Breathe Easy: IFNλ Handles Flu without Triggering a Damaging Inflammatory Response.
  9. A longitudinal study assessing depression in hepatitis C: Does gender play a role in the new-onset depression during interferon-alpha treatment?
  10. Foeniculum vulgare (hinojo): alternativa terapéutica femenina